Home・Elenco Azioni・Erasca Inc

Erasca Inc

Chiusa

18.3 1.1

Acquista Vendi

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

17.38

Massimo

18.57

Metriche Chiave
By Trading Economics
Entrata	-154M -183M
EPS	-0.6
Dipendenti	103
EBITDA	-151M -183M

Raccomandazioni
By TipRanks
Raccomandazioni	Fortemente da comprare
Previsioni per 12 mesi	+22.63% upside

Dividendi
By Acuity
Utili prossimi	17 ago 2026

Statistiche di mercato
By TradingEconomics
Capitalizzazione di Mercato	2.9B 6.2B
Apertura precedente	17.2
Chiusura precedente	18.3

Erasca Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

10 ago 2026, 23:56 UTC

RingCentral Inc. shares advanced in after-market trading, continuing a month-long upward trend and remaining significantly above the 20-day moving average.

10 ago 2026, 23:56 UTC

Aramark shares are higher in after-market trading, recovering from an early decline. The stock remains below its 20-day moving average.

10 ago 2026, 23:56 UTC

Vir Biotechnology Inc. shares advanced in after-market trading, reflecting a modest increase from Monday's close, though still below the 20-day moving average.

10 ago 2026, 23:56 UTC

CF Industries Holdings Inc shares are lower in after-market hours, with no specific news identified to explain the decline. The stock is below its 20-day moving average.

10 ago 2026, 23:56 UTC

Yelp Inc. shares rose slightly in after-market trading, despite being below the 20-day moving average and near the lower end of their one-month range.

10 ago 2026, 23:56 UTC

NN Inc shares are higher in after-market trading, maintaining a position above their 20-day moving average and near the upper end of their one-month range.

10 ago 2026, 23:56 UTC

Johnson Controls International PLC shares are higher in after-market trading, reflecting a modest uptick following Monday's close. The stock remains above its 20-day moving average.

10 ago 2026, 23:56 UTC

B&G Foods Inc. shares are lower in after-market trading, reflecting broader market declines and cautious sentiment following recent labor market data.

10 ago 2026, 23:56 UTC

Dynatrace Inc shares are higher in after-market trading, despite no specific news. Broader market sentiment is influenced by recent economic data.

10 ago 2026, 23:56 UTC

New Fortress Energy shares are higher in after-market trading, reaching 2.94% above Monday's close, significantly above the 20-day moving average.

10 ago 2026, 23:56 UTC

Social Media

NetApp Inc shares are trading higher in after-market hours following an upgrade from Morgan Stanley, driven by increased demand for storage solutions.

10 ago 2026, 23:56 UTC

Ardelyx Inc shares are higher in after-market trading, despite no specific news driving the move. Recent market conditions include cautious optimism following a jobs report.

10 ago 2026, 23:56 UTC

News

Iovance Biotherapeutics reported second-quarter revenue of $99.3 million, a 66% increase, contributing to a rise in shares during after-market hours.

10 ago 2026, 23:56 UTC

Target Corp shares declined in after-market trading, reflecting a directional move since Monday's close. The stock remains above its 20-day moving average.

10 ago 2026, 23:56 UTC

Correlated Moves

Host Hotels & Resorts Inc. is trading lower in after-market hours, reflecting broader declines in small-cap stocks and cautious market sentiment following a recent jobs report.

10 ago 2026, 23:56 UTC

Correlated Moves

ETF Constituents

Financial Select Sector SPDR Fund declines in after-market trading as top holdings Visa, FIS, and PayPal post losses amid flat U.S. markets.

10 ago 2026, 23:56 UTC

Enovix Corp shares are higher in after-market trading, showing strength above their 20-day moving average amid cautious market optimism following recent labor data.

10 ago 2026, 23:56 UTC

Correlated Moves

indie Semiconductor Inc's shares are lower in after-market hours, influenced by broader market caution and a decline in the Russell 2000 Index.

10 ago 2026, 23:56 UTC

Hawaiian Electric Industries shares are lower in after-market hours, with no specific news identified. The stock remains below its 20-day moving average.

10 ago 2026, 23:56 UTC

Quantumscape Corp shares traded lower in after-market hours, with no specific news identified. The stock remains above its 20-day moving average.

10 ago 2026, 23:56 UTC

Tower Semiconductor shares are higher in after-market hours, with no specific news identified. The stock remains well above its 20-day moving average.

10 ago 2026, 23:56 UTC

Correlated Moves

US 5Y Treasury Bond Index trades roughly flat as traders reassess September rate hike odds after a jobs report showed a decline of 23,000 jobs.

10 ago 2026, 23:56 UTC

Correlated Moves

US 10Y Treasury Bond Index trades near unchanged as traders reassess September rate hike odds following a jobs report indicating a decline of 23,000 jobs.

10 ago 2026, 23:52 UTC

Sarepta Therapeutics shares are lower in after-market hours, with no specific news identified for the decline amid broader market sentiment influenced by labor report data.

10 ago 2026, 23:52 UTC

Correlated Moves

ETF Constituents

Macro News

Social Media

Energy Select Sector SPDR Fund lower in after-market hours despite crude oil prices rising to $82.25 amid concerns over the Strait of Hormuz reopening.

10 ago 2026, 23:52 UTC

Event

News

Social Media

Plug Power shares are higher in after-market trading following strong second-quarter results that exceeded analyst expectations and an improved revenue growth outlook.

10 ago 2026, 23:51 UTC

Modine Manufacturing Co shares are higher in after-market trading, buoyed by last Friday's labor report that reduced expectations for Federal Reserve rate hikes.

10 ago 2026, 23:51 UTC

Correlated Moves

Stanley Black & Decker Inc shares declined in after-market trading amid weak market performance and downward pressure from recent labor market data.

10 ago 2026, 23:51 UTC

Shoals Technologies Group Inc shares are lower in after-market trading. Broader market sentiment is affected by a recent labor report and Fed rate hike expectations.

10 ago 2026, 23:51 UTC

Hilltop Holdings Inc is trading lower in after-market hours, continuing a decline since Monday's close amid broader market sentiment influenced by a weak labor report.

Confronto tra pari

Modifica del prezzo

Erasca Inc Previsione

Obiettivo di Prezzo

By TipRanks

22.63% in crescita

Previsioni per 12 mesi

Media 22.22 USD 22.63%

Alto 30 USD

Basso 18 USD

Basato su 9 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Erasca Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Fortemente da comprare

9 ratings

Acquista

Mantieni

Vendi

Basato sugli analisti di 9 che hanno fornito valutazioni azionarie a Erasca Inc - Dist negli ultimi 3 mesi.

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

Chi Siamo Erasca Inc

Erasca, Inc., a clinical-stage precision oncology company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's lead product is naporafenib which is in phase 1b trial for patients with RAS Q16X solid tumors and plans to initiate a pivotal Phase 3 trial for patients with NRASm melanoma. It also develops ERAS-007, an oral inhibitor of ERK1/2 for the treatment of non-small cell lung and colorectal cancer, and advanced gastrointestinal malignancies; and ERAS-601, an oral SHP2 inhibitor for patients with advanced or metastatic solid tumors. In addition, it is developing ERAS-801, a central nervous system-penetrant EGFR inhibitor which is in phase 1 clinical trials for the treatment of patients with recurrent glioblastoma multiforme. The company entered into license agreement with Novartis to develop, manufacture, use, and commercialize naporafenib; Katmai Pharmaceuticals, Inc. to develop, manufacture, use, and commercialize ERAS-801 and certain other related compounds; and NiKang Therapeutics, Inc. to develop and commercialize ERAS-601 and certain other related compounds. Erasca, Inc. was incorporated in 2018 and is headquartered in San Diego, California.